The Trump administration took a roughly 10% stake in Intel, becoming its largest shareholder. This move, unlike previous government interventions during crises, aims to bolster American competitiveness against China in the AI chip race. The CHIPS and Science Act already provided billions in grants, now converted into equity. This action, while aiming to onshore chip manufacturing and reduce reliance on foreign suppliers like Taiwan's TSMC, also carries risks of political fallout and potential interference in Intel's business decisions. Experts cite the need for government intervention to compete with heavily subsidized foreign competitors, but acknowledge potential drawbacks.

Prepared by Christopher Adams and reviewed by editorial team.